Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**MT-ND1 pseudogene 19 (MTND1P19)** is classified as a pseudogene related to the mitochondrial gene MT-ND1, which encodes a core subunit of mitochondrial respiratory chain complex I involved in electron transport[4][6][7]. Pseudogenes such as MTND1P19 do not encode functional proteins due to mutations or incomplete sequences and are generally considered non-functional genomic elements, though some may have regulatory or transcriptional roles in specific contexts. There is no evidence that MTND1P19 is a drug target, involved in biological processes, associated with disease states, or interacts with drugs. The canonical mitochondrial gene, MT-ND1, is important in oxidative phosphorylation and associated with various mitochondrial diseases, but this does not apply to the pseudogene[1][3][5]. **Key notes**: - MTND1P19 is a *nuclear-encoded pseudogene* of the mitochondrial MT-ND1 gene; it does not produce a functional protein[4][6][7]. - It is not referenced as a therapeutic target, biomarker, or having disease relevance in current sources. - There may be confusion with the functional mitochondrial gene MT-ND1, which is a bona fide therapeutic target and biomarker, but MTND1P19 itself does not function in these roles. - Pseudogenes may appear in transcriptomic datasets, but are generally excluded from target/drug discovery efforts unless shown to have functional roles, which has not been established for MTND1P19 in scientific literature to date[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 19 (MTND1P19).